SE0300457D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0300457D0
SE0300457D0 SE0300457A SE0300457A SE0300457D0 SE 0300457 D0 SE0300457 D0 SE 0300457D0 SE 0300457 A SE0300457 A SE 0300457A SE 0300457 A SE0300457 A SE 0300457A SE 0300457 D0 SE0300457 D0 SE 0300457D0
Authority
SE
Sweden
Prior art keywords
novel compounds
therapy
processes
preparation
pharmaceutical compositions
Prior art date
Application number
SE0300457A
Other languages
Swedish (sv)
Inventor
James Reuberson
Sarah King
Austen Pimm
Andrew Baxter
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0300457A priority Critical patent/SE0300457D0/en
Publication of SE0300457D0 publication Critical patent/SE0300457D0/en
Priority to PCT/SE2004/000215 priority patent/WO2004074287A1/en

Links

Abstract

The invention relates to pyridine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
SE0300457A 2003-02-19 2003-02-19 Novel compounds SE0300457D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0300457A SE0300457D0 (en) 2003-02-19 2003-02-19 Novel compounds
PCT/SE2004/000215 WO2004074287A1 (en) 2003-02-19 2004-02-18 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300457A SE0300457D0 (en) 2003-02-19 2003-02-19 Novel compounds

Publications (1)

Publication Number Publication Date
SE0300457D0 true SE0300457D0 (en) 2003-02-19

Family

ID=20290457

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300457A SE0300457D0 (en) 2003-02-19 2003-02-19 Novel compounds

Country Status (2)

Country Link
SE (1) SE0300457D0 (en)
WO (1) WO2004074287A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1651606B1 (en) * 2003-07-30 2012-10-24 Xenon Pharmaceuticals Inc. Pyridyl derivatives and their use as therapeutic agents
CA2563699C (en) 2004-04-23 2014-03-25 Exelixis, Inc. Kinase modulators and method of use
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
FR2880540B1 (en) * 2005-01-13 2008-07-11 Aventis Pharma Sa USE OF PURINE DERIVATIVES AS INHIBITORS OF HSP90 PROTEIN
CN101146793A (en) 2005-02-16 2008-03-19 先灵公司 Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
KR20070107046A (en) 2005-02-16 2007-11-06 쉐링 코포레이션 Heterocyclic substituted piperazines with cxcr3 antagonist activity
CN101460482B (en) 2006-03-21 2013-03-27 默沙东公司 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
EP2043655A2 (en) 2006-04-25 2009-04-08 Astex Therapeutics Limited Purine and deazapurine derivatives as pharmaceutical compounds
AU2007272884A1 (en) 2006-07-14 2008-01-17 Pharmacopeia, Inc. Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity
TW200827346A (en) * 2006-11-03 2008-07-01 Astrazeneca Ab Chemical compounds
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994456A (en) * 1989-03-01 1991-02-19 Nisshin Flour Milling Co., Ltd. Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
GB9514160D0 (en) * 1994-07-25 1995-09-13 Zeneca Ltd Aromatic compounds
FR2802533B1 (en) * 1999-12-17 2002-02-15 Sanofi Synthelabo PHENOXYPROPANOLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EE200200711A (en) * 2000-06-26 2004-06-15 Pfizer Products Inc. Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents

Also Published As

Publication number Publication date
WO2004074287A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
SE0301700D0 (en) Novel compounds
SE0301653D0 (en) Novel compounds
SE0302811D0 (en) Novel compounds
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200800999A (en) Novel compounds
HK1086832A1 (en) Substituted benzosulphonamides as potentiators of glutamate receptors
TW200738659A (en) Novel compounds
SE0200920D0 (en) Novel compounds
CO5660287A2 (en) DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE
UA86591C2 (en) Pyrrolodihydroisoquinolines as pde10 inhibitors, pharmaceutical composition based thereon
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
ITMI20031570A1 (en) COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
SE0401762D0 (en) Novel compounds
NO20062605L (en) Pharmaceutical formulation containing flavoring substances with improved pharmaceutical properties
MX2007003216A (en) Substituted chroman derivatives, medicaments and use in therapy.
EA200701172A1 (en) 2-ALKOXI-3,4,5-TRIHYDROXIALKYLAMIDES, THEIR RECEIVING, COMPOSITIONS, THEIR CONTAINING, AND APPLICATION
SE0302139D0 (en) Novel compounds
DE602004024213D1 (en) Aminopropanolderivate
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
MX2007007027A (en) Piperazinyl pyridine derivatives as anti-obesity agents.
SE0303541D0 (en) New compounds
NO20042158L (en) Substituted 4-phenyl-tetrahydroisoquinolines, process for their preparation, use thereof as medicaments, in addition to medicaments containing the same
MXPA05008099A (en) N-aryl heteroaromatic products, compositions containing same and use thereof.